Literature DB >> 20664054

An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.

Lan V Pham1, Archito T Tamayo, Changping Li, Carlos Bueso-Ramos, Richard J Ford.   

Abstract

The nuclear factor of activated T cells (NFAT) family of transcription factors functions as integrators of multiple signaling pathways by binding to chromatin in combination with other transcription factors and coactivators to regulate genes central for cell growth and survival in hematopoietic cells. Recent experimental evidence has implicated the calcineurin/NFAT signaling pathway in the pathogenesis of various malignancies, including diffuse large B-cell lymphoma (DLBCL). However, the molecular mechanism(s) underlying NFATc1 regulation of genes controlling lymphoma cell growth and survival is still unclear. In this study, we demonstrate that the transcription factor NFATc1 regulates gene expression in DLBCL cells through a chromatin remodeling mechanism that involves recruitment of the SWItch/Sucrose NonFermentable chromatin remodeling complex ATPase enzyme SMARCA4 (also known as Brahma-related gene 1) to NFATc1 targeted gene promoters. The NFATc1/Brahma-related gene 1 complex induces promoter DNase I hypersensitive sites and recruits other transcription factors to the active chromatin site to regulate gene transcription. Targeting NFATc1 with specific small hairpin RNA inhibits DNase I hypersensitive site formation and down-regulates target gene expression. Our data support a novel epigenetic control mechanism for the transcriptional regulation of growth and survival genes by NFATc1 in the pathophysiology of DLBCL and suggests that targeting NFATc1 could potentially have therapeutic value.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664054      PMCID: PMC2981542          DOI: 10.1182/blood-2009-12-257378

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

Review 1.  Current trends in large cell lymphoma.

Authors:  R I Fisher; P Shah
Journal:  Leukemia       Date:  2003-10       Impact factor: 11.528

2.  The human IL-3 locus is regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-specific activities.

Authors:  Abbas Hawwari; Joanna Burrows; Mathew A Vadas; Peter N Cockerill
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

3.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion.

Authors:  Sebastien Jauliac; Cristina López-Rodriguez; Leslie M Shaw; Lawrence F Brown; Anjana Rao; Alex Toker
Journal:  Nat Cell Biol       Date:  2002-07       Impact factor: 28.824

4.  Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development.

Authors:  Tian H Chi; Mimi Wan; Peggy P Lee; Koichi Akashi; Daniel Metzger; Pierre Chambon; Christopher B Wilson; Gerald R Crabtree
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

Review 5.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

6.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

7.  A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas.

Authors:  Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Piao Lo; Nicholas Terry; Pamela S Reid; Richard J Ford
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

8.  A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts.

Authors:  Joel W Neal; Neil A Clipstone
Journal:  J Biol Chem       Date:  2003-02-21       Impact factor: 5.157

9.  Transcription cooperation by NFAT.C/EBP composite enhancer complex.

Authors:  Teddy T C Yang; Chi-Wing Chow
Journal:  J Biol Chem       Date:  2003-02-26       Impact factor: 5.157

10.  BRG1 directly regulates nucleosome structure and chromatin looping of the alpha globin locus to activate transcription.

Authors:  Shin-Il Kim; Emery H Bresnick; Scott J Bultman
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

View more
  20 in total

1.  Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.

Authors:  Lirong Pei; Jeong-Hyeon Choi; Jimei Liu; Eun-Joon Lee; Brian McCarthy; James M Wilson; Ethan Speir; Farrukh Awan; Hongseok Tae; Gerald Arthur; Jennifer L Schnabel; Kristen H Taylor; Xinguo Wang; Dong Xu; Han-Fei Ding; David H Munn; Charles Caldwell; Huidong Shi
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

2.  NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes.

Authors:  Leonardo K Teixeira; Nina Carrossini; Cristiane Sécca; José E Kroll; Déborah C DaCunha; Douglas V Faget; Lilian D S Carvalho; Sandro J de Souza; João P B Viola
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

3.  Release the ink4a/arf growth suppression by "u" and "me"?

Authors:  Shuo Qie; Nianli Sang
Journal:  Cell Cycle       Date:  2011-01-15       Impact factor: 4.534

4.  Epstein-Barr virus oncoprotein super-enhancers control B cell growth.

Authors:  Hufeng Zhou; Stefanie C S Schmidt; Sizun Jiang; Bradford Willox; Katharina Bernhardt; Jun Liang; Eric C Johannsen; Peter Kharchenko; Benjamin E Gewurz; Elliott Kieff; Bo Zhao
Journal:  Cell Host Microbe       Date:  2015-01-29       Impact factor: 21.023

5.  Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal.

Authors:  Christine A Marian; Mateusz Stoszko; Lili Wang; Matthew W Leighty; Elisa de Crignis; Chad A Maschinot; Jovylyn Gatchalian; Benjamin C Carter; Basudev Chowdhury; Diana C Hargreaves; Jeremy R Duvall; Gerald R Crabtree; Tokameh Mahmoudi; Emily C Dykhuizen
Journal:  Cell Chem Biol       Date:  2018-09-06       Impact factor: 8.116

6.  NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.

Authors:  Pedro I Lucena; Douglas V Faget; Emilia Pachulec; Marcela C Robaina; Claudete E Klumb; Bruno K Robbs; João P B Viola
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

Review 7.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

8.  NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway.

Authors:  Wenwen Xu; Junjie Gu; Qingling Ren; Yanqiu Shi; Qinhua Xia; Jing Wang; Suli Wang; Yingchun Wang; Jinhua Wang
Journal:  Tumour Biol       Date:  2015-10-26

Review 9.  NFAT gene family in inflammation and cancer.

Authors:  M-G Pan; Y Xiong; F Chen
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

10.  B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.

Authors:  Li Li; Jun Zhang; Juan Chen; Zijun Y Xu-Monette; Yi Miao; Min Xiao; Ken H Young; Sa Wang; L Jeffrey Medeiros; Michael Wang; Richard J Ford; Lan V Pham
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.